1.
Theocharides A, Passweg JR, Medinger M, Looser R, Li S, Hao-Shen H, Buser AS, Gratwohl A, Tichelli A, Skoda RC. The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders. Haematologica [Internet]. 2008Dec.2 [cited 2026Nov.9];93(12):1890-3. Available from: https://haematologica.org/article/view/5114